Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Organocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for anticancer drug development.
Novel synthesis method for N-N axis chiral compounds delivering high ee and mild conditions. Reliable supplier for pharma intermediates ensuring cost reduction.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Patent CN113980028A details a novel organocatalytic route for chiral spiro indolones. This method offers mild conditions, high stereoselectivity, and scalable manufacturing for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-purity indolo derivatives. This patent offers cost-effective scale-up solutions for global pharmaceutical intermediates manufacturing supply chains.
Discover a novel asymmetric synthesis method for axially chiral indole-naphthalene compounds using chiral phosphoric acid. High enantioselectivity and mild conditions for API manufacturing.
Novel nitroxide catalyst enables high-yield azlactone ring opening. Reduces costs in pharmaceutical intermediate manufacturing with superior enantioselectivity.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Novel chiral phosphoric acid catalyzed synthesis of axially chiral indole-naphthalene compounds with high enantioselectivity for pharmaceutical applications.
Patent CN112920173A details a mild chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing potential.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and cost reduction in API manufacturing.
Novel 5 5 tetralone skeleton chiral phosphoric acid patent CN105111228A offers enhanced acidity and enantioselectivity for pharmaceutical intermediates with cost effective synthesis
Patent CN110452150A reveals mild chiral phosphoric acid catalysis. Enables cost reduction in fine chemical intermediates manufacturing with high enantioselectivity.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles with high enantioselectivity for anticancer drug development and pharmaceutical intermediates.
Patent CN107698590B details a novel asymmetric [3+2] cyclization for chiral carbocyclic purine nucleosides, offering high yields and enantioselectivity for reliable pharmaceutical intermediate supply.
Patent CN110467555B reveals a novel chiral phosphoric acid catalyzed method for synthesizing axially chiral indoles with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN111777637B discloses a novel oxindole-derived phosphine catalyst enabling mild asymmetric cyclizations with excellent yields and supply chain stability.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering reliable supply chain solutions.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity axial chiral aryl indoles, offering cost-effective API intermediate manufacturing.